Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Collin J Fitzpatrick

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
NPJ Vaccines|March 3, 2021
A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in miceJohn J Suschak, Joseph W Golden, Collin J Fitzpatrick, et al.
Virus Research|July 17, 2023
Induced protection from a CCHFV-M DNA vaccine requires CD8<sup>+</sup> T cellsJoseph W Golden, Collin J Fitzpatrick, John J Suschak, et al.
Plos Pathogens|May 19, 2022
The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected miceJoseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Nature Communications|February 26, 2024
Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virusAura R Garrison, Vanessa Moresco, Xiankun Zeng, et al.
Frontiers in Cellular and Infection Microbiology|April 25, 2022
Junin Virus Activates p38 MAPK and HSP27 Upon EntryCollin J Fitzpatrick, Rajini R Mudhasani, Louis A Altamura, et al.
Viruses|May 27, 2026
Dynamic Changes in Host Immune Response During Crimean-Congo Hemorrhagic Fever and Severe Fever with Thrombocytopenia Syndrome in MiceDoreswamy Kenchegowda, Brian D Carey, Joshua Shamblin, et al.
Plos Neglected Tropical Diseases|September 19, 2017
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse modelsAura R Garrison, Charles J Shoemaker, Joseph W Golden, et al.
Science Advances|July 17, 2019
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infectionJoseph W Golden, Charles J Shoemaker, Michael E Lindquist, et al.
The Journal of General Virology|May 7, 2021
Human convalescent plasma protects K18-hACE2 mice against severe respiratory diseaseJoseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Plos Pathogens|September 27, 2019
Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosisDarci R Smith, Charles J Shoemaker, Xiankun Zeng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
NPJ Vaccines|March 3, 2021
A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in miceJohn J Suschak, Joseph W Golden, Collin J Fitzpatrick, et al.
Virus Research|July 17, 2023
Induced protection from a CCHFV-M DNA vaccine requires CD8<sup>+</sup> T cellsJoseph W Golden, Collin J Fitzpatrick, John J Suschak, et al.
Plos Pathogens|May 19, 2022
The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected miceJoseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Nature Communications|February 26, 2024
Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virusAura R Garrison, Vanessa Moresco, Xiankun Zeng, et al.
Frontiers in Cellular and Infection Microbiology|April 25, 2022
Junin Virus Activates p38 MAPK and HSP27 Upon EntryCollin J Fitzpatrick, Rajini R Mudhasani, Louis A Altamura, et al.
Viruses|May 27, 2026
Dynamic Changes in Host Immune Response During Crimean-Congo Hemorrhagic Fever and Severe Fever with Thrombocytopenia Syndrome in MiceDoreswamy Kenchegowda, Brian D Carey, Joshua Shamblin, et al.
Plos Neglected Tropical Diseases|September 19, 2017
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse modelsAura R Garrison, Charles J Shoemaker, Joseph W Golden, et al.
Science Advances|July 17, 2019
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infectionJoseph W Golden, Charles J Shoemaker, Michael E Lindquist, et al.
The Journal of General Virology|May 7, 2021
Human convalescent plasma protects K18-hACE2 mice against severe respiratory diseaseJoseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Plos Pathogens|September 27, 2019
Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosisDarci R Smith, Charles J Shoemaker, Xiankun Zeng, et al.
Pageof 2